Exiqon Releases Additional 235 Pre-Validated qPCR Assays for Mouse and Rat microRNAs
Complete the form below to unlock access to ALL audio articles.
Exiqon A/S has announced the launch of additional 235 pre-validated miRCURY LNA™ Universal RT microRNA qPCR assays for sensitive and specific quantification of microRNAs.
With the launch of the new assays, Exiqon now offers 1731 pre-validated qPCR assays for human, mouse and rat microRNAs. In addition to the pre-validated qPCR assays, Exiqon offers to custom design LNA™-enhanced qPCR assays for any microRNA.
The proprietary design software which is available on the company’s website, is based on an advanced design algorithm which applies more 60 design parameters.
“With this launch, Exiqon offers the highest number of pre-validated assays for human, mouse and rat microRNAs on the market”, said Vice President Sales & Marketing, Dr. Henrik M. Pfundheller and added: “We have seen an increasing demand for rodent microRNA assays - in particular for detection of microRNAs from mouse serum/plasma samples. We are dedicated to developing and marketing LNA™-enhanced microRNA qPCR products for new and challenging applications such as serum and plasma analyses”.
Exiqon’s product line for microRNA qPCR also includes ready-to-use panels for genome-wide screening of human, mouse and rat microRNAs as well as RT and Master Mix kits and a qPCR data analysis software.